Cengild Medical Berhad (KLSE: CENGILD)

Market Cap	208.23M
Revenue (ttm)	66.85M
Net Income (ttm)	11.08M
Shares Out	832.91M
EPS (ttm)	0.01
PE Ratio	18.80
Forward PE	n/a
Dividend	0.01 (2.96%)
Ex-Dividend Date	Sep 10, 2024

Volume	62,400
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	0.240 - 0.350
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Cengild Medical Berhad

Cengild Medical Berhad, an investment holding company, operates a medical center in Malaysia. The company offers various care and treatment consultant services for gastrointestinal and liver diseases, morbid obesity, and oncology and urological conditions; general cardiology and gynecology assessment; gastroenterology and hepatology; anesthesiology, endocrinology, general surgery, internal medicine, orthopedic, plastic and reconstructive surgery, radiology, rheumatology, and thoracic surgery; ear, nose and throat; gastrointestinal surgeries, in...

• Industry: Health Services
• Founded: 2017
• Employees: 159
• Stock Exchange: Bursa Malaysia
• Ticker Symbol: CENGILD

Financial Performance

In 2024, Cengild Medical Berhad's revenue was 66.85 million, a decrease of -4.88% compared to the previous year's 70.28 million. Earnings were 11.08 million, a decrease of -16.64%.